Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €23.01 EUR
Change Today -0.285 / -1.22%
Volume 0.0
GM0N On Other Exchanges
Symbol
Exchange
Frankfurt
As of 2:08 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

2560 General Armistead Avenue

Audubon, PA 19403

United States

Phone: 610-930-1800

Fax:

Globus Medical, Inc., a medical device company, focuses on the design, development and commercialization of musculoskeletal implants. The company focuses on products to treat patients with spine disorders. All of the company’s products fall into one of two categories: innovative fusion or disruptive technologies. The company offers approximately 130 products for the treatment of spine disorders. Innovative Fusion Products The company’s innovative fusion products consist of fusion products to treat various spinal disorders for theentire spine and can be used in various surgical approaches. The company’s innovative fusion products address the entire spine to treat degenerative, deformity, tumor, and trauma conditions. In 2013, the company introduced a pedicle screw platform, CREO. This new system is optionally modular and offers lower profile constructs along with various options to meet surgical and patient needs. CREO includes the company’s convenient non-threaded locking cap design that eases building of thoracolumbar fixation constructs to readily adapt to the patient’s anatomy and condition, for a range of clinical applications. In 2014, among several other new products, the company launched several additions to the CREO platform, including streamlined and intuitive instruments that offer surgeons options for almost any situation or preference. Disruptive Technologies Products The company’s portfolio of approved and pipeline disruptive technology products includes products that allow for minimally invasive surgical (MIS) techniques, as well as new treatment alternatives, including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies, as well as interventional pain management solutions, including treatments for vertebral compression fractures. The company’s MIS products enable a surgeon to perform a procedure less invasively to minimize tissue disruption and maximize native anatomy, which may lead to better patient recovery and fewer approach-related complications. Its MARS 3V retractor system facilitates smaller incisions with the use of positionable radiolucent retractor blades to access the surgical site and to allow both direct and radiographic visualization. The company offers ALTERA, an articulating expandable spacer. Key products in this family, including CALIBER, RISE and LATIS interbody spacers, are designed to enable minimally disruptive delivery through small MIS incisions with streamlined implants and instruments. The company offers various innovative fixation options, including plates and pedicle screw systems designed for minimally invasive insertion. Similarly, other Disruptive Technology products include the company’s motion preservation offerings, such as SECURE-C and SECURE-CR, which are next-generation cervical arthroplasty devices that allow segmental motion, are semi-constrained, and provide alternatives to fusion in the treatment of degenerative conditions. In 2014, the company launched MONUMENT, its interbody implant intended to aid in the reduction of a grade 1 spondylolisthesis using its built-in, self-locking mechanical reduction feature. The company’s advanced biomaterials products, including bioactive glass-based KINEX and SIGNIFY bone void fillers and CONDUCT ceramic-collagen, are well suited for pelvic/extremity and posterolateral spinal fusion procedures. Its SHIELD and AFFIRM products allow for the treatment of painful vertebral compression fractures. Clinical Development Programs In addition to the products the company markets, it develops and tests new spine products. The company is required to conduct clinical trials to obtain U.S. Food and Drug Administration (FDA) approval or clearance to market some of those products. The company received its first FDA pre-market approval for its SECURE-C Cervical Artificial Disc in 2012 and is conducting other clinical trials under FDA-approved investigational device exemptions, including ACADIA and TRIUMPH. Both ACADIA and TRIUMPH are European Conformity marked (CE marked) and available for sale in ce

Page 12Next Page
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GM0N:GR €23.01 EUR -0.285

GM0N Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Integra LifeSciences Holdings Corp $60.53 USD +0.63
K2M Group Holdings Inc $23.15 USD -0.31
LDR Holding Corp $43.01 USD 0.00
NuVasive Inc $47.29 USD -0.23
Orthofix International NV $33.22 USD +0.275
View Industry Companies
 

Industry Analysis

GM0N

Industry Average

Valuation GM0N Industry Range
Price/Earnings 25.5x
Price/Sales 5.0x
Price/Book 4.0x
Price/Cash Flow 25.3x
TEV/Sales 4.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLOBUS MEDICAL INC - A, please visit www.globusmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.